STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Heritage Cannabis Announces Launch of ArthroCBD in the United States

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Heritage Cannabis Holdings Corp. (OTCQX: HERTF) has launched ArthroCBD, a newly developed hemp product designed for symptomatic relief. Each softgel capsule contains 25 mg of CBD and 6 mg of Beta caryophyllene, utilizing VESIsorb® technology for enhanced absorption. This clinically tested product aims to offer effective relief with minimal side effects, eliminating THC to prevent adverse effects common in other hemp products. The launch marks the beginning of a pipeline of over seven new medicinal hemp-based offerings planned by Heritage, which operates licensed facilities in Canada.

Positive
  • Launch of ArthroCBD, targeting symptomatic relief for consumers.
  • Product utilizes VESIsorb® for significantly improved absorption rates.
  • Clinically tested product offers safety with no THC.
  • Plans to introduce over seven additional medicinal hemp-based products.
Negative
  • None.

Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced the launch of ArthroCBD, an innovative hemp brand created to provide a solution to those seeking symptomatic relief. The new product, available for purchase on arthrocbd.com, is backed by unmatched scientific clinical data published in a peer reviewed journal.

ArthroCBD is a softgel capsule with 25 mg of CBD and 6 mg of Beta caryophyllene, and is formulated using VESIsorb®, which provides dramatically improved absorption versus competitive oral CBD products on the market. These absorption levels result in rapid onset of action and long lasting relief. ArthroCBD also has all traces of THC removed to avoid the problematic adverse effects people can get from many other hemp based products.

“We are excited to launch our clinically tested ArthroCBD softgel capsules for those seeking daily relief from physical strain. Physicians, pharmacists, and other health care practitioners all want the same thing – to provide the best treatment for patients with the least side effects. ArthroCBD now provides that option with a highly effective hemp based CBD product,” said Umar Syed, President, Medical Products. “Carefully formulated CBD with pharmaceutical technology, high quality tested ingredients, and clinical testing to prove product performance is a logical step in the evolution of hemp based CBD products. Our focus is to finally provide patients and the medical and healthcare communities with products based on credible data that they can trust to work well and safely.”

With more than three decades of experience in pharmaceutical medicine and OTC consumer marketing, Heritage’s team is bringing products to market to help many segments of the population suffering from chronic ailments. The Company’s U.S. products use VESIsorb®, a proven technology that helps boost the performance of pharmaceutical and wellness products. VESIsorb® dramatically improves the stability, reliable high absorption, rapid onset of action of products and is backed by a robust body of supporting scientific evidence spanning several decades.

The ArthroCBD launch marks the first of a pipeline of over 7 new medicinal hemp based CBD product offerings planned by Heritage.

About Heritage Cannabis Holdings Corp.

Heritage is a leading cannabis products company operating two licensed manufacturing facilities in Canada and offering innovative products to both the medical and recreational legal cannabis markets in Canada and US. The company has an extensive portfolio of high quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, feelgood. and ArthroCBD.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

“Clint Sharples”

Clint Sharples
CEO

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

FAQ

What is ArthroCBD by Heritage Cannabis?

ArthroCBD is a new hemp product by Heritage Cannabis Holdings designed to provide symptomatic relief, featuring 25 mg of CBD and 6 mg of Beta caryophyllene.

What technology does ArthroCBD use?

ArthroCBD utilizes VESIsorb® technology, which enhances absorption compared to other oral CBD products.

Is there any THC in ArthroCBD?

No, ArthroCBD is formulated to remove all traces of THC, minimizing potential adverse effects.

How many new products are planned by Heritage Cannabis?

Heritage Cannabis plans to launch over seven new medicinal hemp-based CBD products following ArthroCBD.

What is the stock symbol for Heritage Cannabis Holdings?

The stock symbol for Heritage Cannabis Holdings is HERTF, traded on the OTC markets.

HERITAGE CANNABIS HLDGS

OTC:HERTF

HERTF Rankings

HERTF Latest News

HERTF Stock Data

3.47M
868.29M
14.03%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Kelowna